Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions Announces Launch of Aquapheresis Therapy Using Aquadex FlexFlow® System at the Baylor Scott & White Health System in Texas
EDEN PRAIRIE, Minn. , Jan. 22, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Texas -based health system, Baylor Scott & White Health has initiated offering aquapheresis therapy using the company’s Aquadex FlexFlow ® system at its Baylor Scott & White Medical Center in
View HTML
Toggle Summary CHF Solutions Announces Presentation of Clinical Data with Aquadex FlexFlow® Highlighting Efficacy and Simplicity of Use In Treating Critical Care Patients
EDEN PRAIRIE, Minn. , Jan. 08, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced results from an investigator-initiated retrospective analysis of utilization of the Aquadex FlexFlow aquapheresis system at Lenox Hill Hospital in New York City .
View HTML
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Memphis Methodist Le Bonheur Healthcare System
EDEN PRAIRIE, Minn. , Dec. 03, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Memphis, Tennessee -based health system, Methodist Le Bonheur, has initiated offering aquapheresis therapy to patients suffering from fluid overload using the company’s Aquadex FlexFlow system.
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Nov. 15, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on November 12, 2019 , the independent directors approved eight equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to eight individuals entering
View HTML
Toggle Summary CHF Solutions, Inc. Announces Third Quarter Financial Results and Provides Company Update
EDEN PRAIRIE, Minn. , Nov. 05, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced today its results for
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
EDEN PRAIRIE, Minn. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. ( CHF Solutions or the Company) (NASDAQ:CHFS) today announced the pricing of a registered direct offering of 1,219,076 shares of its common stock (or common equivalents) at a price to the public of $1.12 per share, for
View HTML
Toggle Summary CHF Solutions, Inc. Announces Sales Force Realignment To Increase Focus On Cardiac Surgery And Eventually Pediatrics
EDEN PRAIRIE, Minn. , Nov. 01, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced a sales force
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Third Quarter 2019 Financial Results and Corporate Update on November 5, 2019
EDEN PRAIRIE, Minn. , Oct. 29, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2019 financial results will be released on Tuesday, November 5, 2019 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
View HTML
Toggle Summary Abington Hospital Begins a 344 Patient Retrospective Clinical Study to Analyze Experience with CHF Solutions’ Aquadex FlexFlow® System
EDEN PRAIRIE, Minn. , Oct. 24, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that investigators at Abington Hospital-Jefferson Health in Abington, Pennsylvania are conducting a retrospective analysis of their experience using the company’s Aquadex FlexFlow System in heart
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
EDEN PRAIRIE, Minn. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. ( CHF Solutions or the Company) (NASDAQ:CHFS) today announced the pricing of a registered direct offering of 575,830 shares of its common stock at a price to the public of $1.15 per share, for gross proceeds of
View HTML